Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure

Experimental and Clinical Psychopharmacology

Volumn 6, Issue 2, 1998, Pages 169-178

  Oliveto, Alison H ^a   Rosen, Marc I ^b   Kosten, Therese A ^b   Hameedi, Faiq A ^b   Woods, Scott W ^b   Kosten, Thomas R ^b  

^a West Haven   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROMORPHONE; METHADONE; NALOXONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISCRIMINATION LEARNING; DRUG DISCRIMINATION; FEMALE; HUMAN; MALE; OPIATE ADDICTION; SCORING SYSTEM; SELF REPORT; WITHDRAWAL SYNDROME;

ADULT; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROMORPHONE; MALE; METHADONE; NALOXONE; OPIOID-RELATED DISORDERS;

EID: 0031748769     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.6.2.169     Document Type: Article

References (22)

1. Bickel, W. K., Oliveto, A. H., Kamien, J. B., Higgins, S. T., & Hughes, J. R. (1993). A novel-response procedure enhances the specificity and sensitivity of a triazolam discrimination in humans. Journal of Pharmacology and Experimental Therapeutics, 264, 360-367.
2. France, C. P., de Costa, B. R., Jacobson, A. E., Rice, K. R., & Woods, J. H. (1990). Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone. Journal of Pharmacology and Experimental Therapeutics, 252, 600-604.
3. France, C. P., & Woods, J. H. (1987). Morphine, saline and naltrexone discrimination in morphine-treated pigeons. Journal of Pharmacology and Experimental Therapeutics, 242, 195- 202.
4. France, C. P., & Woods, J. H. (1989). Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 250, 937-943.
5. France, C. P., & Woods, J. H. (1990). Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons. Journal of Pharmacology and Experimental Therapeutics, 254, 626-632.
6. Gellert, V. F., & Holtzman, S. G. (1979). Discriminative stimulus effects of naltrexone in the morphine-dependent rat. Journal of Pharmacology and Experimental Therapeutics, 211, 596-605.
7. Holtzman, S. G. (1985). Discriminative stimulus effects of morphine withdrawal in the dependent rat: Suppression by opiate and nonopiate drugs. Journal of Pharmacology and Experimental Therapeutics, 233, 80-86.
8. Jaffe, J. H., & Martin, W. R. (1985). Opioid analgesics and antagonists. In A. G. Gilman, L. S. Goodman, T. W. Rall, & F. Murad (Eds.), Pharmacological basis of therapeutics (pp. 491- 531). New York: MacMillan.
9. Jasinski, D. R. (1977). Assessment of the abuse potential of morphine-like drugs (methods used in man). In W. R. Martin (Ed.), Drug addiction I (pp. 197-258). New York: Springer- Verlag.
10. Jasinski, D. R., Johnson, R. E., & Kocher, T. R. (1985). Clonidine in morphine withdrawal: Differential effects on signs and symptoms. Archives of General Psychiatry, 42, 1063-1066.
11. Kamien, J. B., Bickel, W. K., Oliveto, A. H., Smith, B. J., Higgins, S. T., & Hughes, J. R. (1994). Triazolam discrimination by humans under a novel-response procedure: Effects of buspirone and lorazepam. Behavioral Pharmacology, 5, 315-325.
12. Kleber, H. D., Riordan, C. E., Rounsaville, B. J., Kosten, T. R., Charney, D. S., Gaspari, J., Hogan, I., & O'Connor, C. (1985). Clonidine in outpatient detoxification from methadone maintenance. Archives of General Psychiatry, 42, 391-394.
13. Kosten, T. R., Rounsaville, B. J., & Kleber, H. D. (1985). Comparison of clinical ratings to self-reports of withdrawal during clonidine detoxification of opiate addicts. American Journal on Drug and Alcohol Abuse, 11, 1-10.
14. Martin, W. R., Sloan, J. W., Sapiro, J. D., & Jasinski, D. R. (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clinical Pharmacology and Therapeutics, 12, 245-258.
15. Oliveto, A. H., Bickel, W. K., Kamien, J. B., Hughes, J. R., & Higgins, S. T. (1994). Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure. Psychopharmacology, 114, 417-423.
16. Preston, K. L., Bigelow, G. E., Bickel, W. K., & Liebson, I. A. (1987). Three-choice drug discrimination in opioid-dependent humans: Hydromorphone, naloxone and saline. Journal of Pharmacology and Experimental Therapeutics, 243, 1002- 1009.
17. Preston, K. L., Bigelow, G. E., Bickel, W. K., & Liebson, I. A. (1989). Drug discrimination in human post-addicts: Agonist- antagonist opioids. Journal of Pharmacology and Experimental Therapeutics, 250, 184-196.
18. Preston, K. L., Bigelow, G. E., & Liebson, I. A. (1990). Discrimination of butorphanol and nalbuphine in opioid-dependent subjects. Pharmacology Biochemistry and Behavior, 37, 511-522.
19. Rounsaville, B. J., Kosten, T. R., & Kleber, H. D. (1985). Success and failure at outpatient opioid detoxification: Evaluating the process of clonidine and methadone-assisted withdrawal. Journal of Nervous and Mental Disease, 173, 103-110.
20. Valentino, R. J., Herling, S., & Woods, J. H. (1983). Discriminative stimulus effects of naltrexone in narcotic-naive and morphine- treated pigeons. Journal of Pharmacology and Experimental Therapeutics, 224, 307-313.
21. Winer, B. J. (1962). Statistical principals in experimental design. New York: McGraw-Hill.
22. Zweben, J. E., & Payte, J. T. (1990). Methadone maintenance in the treatment of opioid dependence: A current perspective. Western Journal of Medicine, 152, 588-599.